Acute liver failure due to amoxicillin and amoxicillin/clavulanate

Robert J Fontana, A Obaid Shakil, Joel K Greenson, Ian Boyd, William M Lee, Robert J Fontana, A Obaid Shakil, Joel K Greenson, Ian Boyd, William M Lee

Abstract

The aim of our study is to report upon the presentation of two patients with life-threatening acute liver failure (ALF) due to amoxicillin and amoxicillin/clavulanate. A 59-year-old, Caucasian male presented with ALF 34 days after receiving amoxicillin/clavulanate. Despite aggressive supportive care, he died on hospital day 10. A 42-year-old, Caucasian female presented with ALF 21 days after receiving amoxicillin. She underwent successful liver transplantation on hospital day 19. In both cases, all competing causes of ALF had been excluded, liver pathology was consistent with drug-induced hepatitis, and cases were deemed "definite/highly probable" using causality assessment. Amongst 14 prior ALF/death cases due to amoxicillin/clavulanate, the mean age (62 years), male predominance (57%), and mean delay from drug cessation to presentation (17 days) is similar to what has been reported in patients with self-limited cholestatic hepatitis. Acute liver failure is a rare manifestation of amoxicillin and amoxicillin/clavulanate hepatotoxicity with no obvious clinical features at presentation portending a poor prognosis. Early transfer of patients with severe drug-induced hepatotoxicity (i.e., encephalopathy or coagulopathy) to a transplant center is recommended due to their poor likelihood of recovery.

References

    1. An Med Interna. 2002 Oct;19(10):551-2
    1. Liver Transpl. 2000 Mar;6(2):163-9
    1. J Clin Epidemiol. 1993 Nov;46(11):1323-30
    1. Semin Liver Dis. 2002;22(2):145-55
    1. Semin Liver Dis. 2002;22(2):157-67
    1. Med J Aust. 1992 Feb 17;156(4):285-6
    1. Gut. 2000 Nov;47(5):717-20
    1. Gastroenterol Hepatol. 2000 May;23(5):237-9
    1. Ann Pharmacother. 1999 May;33(5):560-4
    1. Ann Intern Med. 2002 Dec 17;137(12):947-54
    1. Laryngoscope. 2000 Jun;110(6):1050-5
    1. Eur J Med Res. 2001 Apr 20;6(4):139-49
    1. J Clin Pharm Ther. 2001 Jun;26(3):225-9
    1. Drugs Exp Clin Res. 1985;11(11):805-13
    1. Hepatology. 2001 Jan;33(1):123-30
    1. Gut. 1992 Mar;33(3):368-71
    1. Pediatr Infect Dis J. 1998 Oct;17(10):957-62
    1. Panminerva Med. 2003 Jun;45(2):85-94
    1. J Hepatol. 2000 Dec;33(6):949-52
    1. Gastroenterology. 1999 Nov;117(5):1181-6
    1. Hepatology. 1997 Sep;26(3):664-9
    1. J Hepatol. 1990 Sep;11(2):272-6
    1. Arch Intern Med. 1996 Jun 24;156(12):1327-32
    1. J Clin Epidemiol. 1993 Nov;46(11):1331-6
    1. J Hepatol. 1995 Jan;22(1):71-7

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi